NCT01511159 - Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

December 31, 2001

Study Completion Date

December 31, 2001

Conditions

DiabetesHealthy

Interventions

DRUG

liraglutide

Single dose of 6 mcg/kg by inhalation. Progression to open-label trial part will be based on safety data

DRUG

placebo

Single dose by inhalation. Progression to open-label trial part will be based on safety data

DRUG

liraglutide

Single dose of 12 mcg/kg by inhalation. Subjects receive treatment in random order

DRUG

liraglutide

Single dose 6 mcg/kg injected subcutaneously. Subjects receive treatment in random order

DRUG

insulin human

Single dose 0.4 IU/kg by inhalation. Subjects receive treatment in random order

DRUG

insulin human

Single dose 0.08 IU/kg injected subcutaneously. Subjects receive treatment in random order

DRUG

liraglutide

24 mcg/kg by inhalation. Progression to dose level will be based on safety evaluation

Trial Locations (1)

Tranent